Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study

BJU International

Volumn 103, Issue 5, 2009, Pages 597-602

  Porter, Christopher R ^a   Capitanio, Umberto ^b   Perrotte, Paul ^b   Walz, Jochen ^b   Isbarn, Hendrik ^b   Kodama, Koichi ^a   Gibbons, Robert P ^a   Correa Jr , Roy ^a   Karakiewicz, Pierre I ^b,c  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adjuvant radiotherapy; Cause specific; Overall survival; Prostate cancer; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 60449115716     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08133.x     Document Type: Article

References (30)

1. Barre C. Open radical retropubic prostatectomy. Eur Urol 2007 52 : 71 80
2. Simmons MN, Stephenson AJ, Klein EA. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 2007 51 : 1175 84
3. Heidenreich A, Aus G, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2008 53 : 68 80
4. Suardi N, Porter CR, Reuther AM et al. A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 2008 112 : 1254 63
5. Morgan SC, Waldron TS, Eapen L, Mayhew LA, Winquist E, Lukka H. Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer. A systematic review and meta-analysis. Radiother Oncol 2008 88 : 1 9
6. Sidhom MA, Kneebone AB, Lehman M et al. Post-prostatectomy radiation therapy. Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiother Oncol 2008 88 : 10 9
7. Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005 366 : 572 8
8. Thompson IM Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006 296 : 2329 35
9. Trock BJ, Han M, Freedland SJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008 299 : 2760 9
10. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology 2004 64 : 84 9
11. Cozzarini C, Bolognesi A, Ceresoli GL et al. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Rad Oncol, Biol Physics 2004 59 : 674 83
12. Nudell DM, Grossfeld GD, Weinberg VK, Roach M Carroll PR. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology 1999 54 : 1049 57
13. Vicini FA, Ziaja EL, Kestin LL et al. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology 1999 54 : 111 7
14. Porter CR, Kodama K, Gibbons RP et al. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol 2006 176 : 569 74
15. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004 172 : 910 4
16. Stephenson AJ, Scardino PT, Eastham JA et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005 23 : 7005 12
17. Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet 2005 365 : 1429 33
18. Wiegel T, Bottke D, Willich N, Semjonov A, Siegmann A, Stoeckle M. Phase III results of adjuvant radiotherapy versus wait and see in patients with pT3 prostate cancer following radical prostatectomy (ARO 96-02/AUO AP 09/95) [abstract]. Int J Radiat Oncol Biol Phys 2007 69 : S172
19. Vis AN, Schroder FH, van der Kwast TH. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 2006 50 : 258 65
20. Hsu CY, Joniau S, Oyen R, Roskams T, Van Poppel H. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 2007 51 : 121 8
21. Jeldres C, Suardi N, Saad F et al. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol 2008 54 : 97 105
22. Touijer K, Kuroiwa K, Eastham JA et al. Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. Eur Urol 2007 52 : 1090 6
23. Capitanio U, Karakiewicz PI, Jeldres C et al. Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications. Eur Urol 2008 Epub ahead of print
24. Wirth MP, Hakenberg OW, Froehner M. Antiandrogens in the treatment of prostate cancer. Eur Urol 2007 51 : 306 13
25. Capitanio U, Scattoni V, Freschi M et al. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol 2008 54 : 118 25
26. Briganti A, Chun FK, Salonia A et al. A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Eur Urol 2007 51 : 112 9
27. Karakiewicz PI. Editorial comment on: laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results. Eur Urol 2007 52 : 1355 6
28. Stephenson AJ, Shariat SF, Zelefsky MJ et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004 291 : 1325 32
29. Scardino P. Update: NCCN prostate cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 2005 3 (Suppl. 1 S29 33
30. Parker C, Clarke N, Logue J et al. RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). Clin Oncol (R Coll Radiol) 2007 19 : 167 71